Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Quidel Corp Receives CE Mark For Sofia Legionella Fluorescent Immunoassay
Quidel Corp announced that it has received the CE Mark for Sofia Legionella FIA for use on the Sofia Analyzer for the rapid detection of Legionnaires' disease, also known as legionellosis. The CE Mark allows Quidel to launch new Sofia Legionella FIA in Europe.
Latest Developments for Quidel Corp
- Quidel Corp Completes Acquisition Of BioHelix Corporation
- Quidel Corp Completes Acquisition Of BioHelix Corporation
- Quidel Corp Receive FDA Clearance For Clostridium Difficile Assay And Quantstudio DX And 7500 Fast DX Real-Time PCR Instruments
- Quidel Corp Issues Q4 2012 Revenue Guidance Above Analysts' Estimates
- Share this
- Link this
- Digg this


Follow Reuters